Author:
Colosia Ann D,Masaquel Anthony,Hall Caroline Breese,Barrett Amy M,Mahadevia Parthiv J,Yogev Ram
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Committee on Infectious Diseases: From the American Academy of Pediatrics: policy statements–Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009, 124 (6): 1694-1701.
2. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al: The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009, 360 (6): 588-598. 10.1056/NEJMoa0804877.
3. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, et al: Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010, 375 (9725): 1545-1555. 10.1016/S0140-6736(10)60206-1.
4. Hall CB, Walsh EE: Respiratory syncytial virus. In Textbook of Pediatric Infectious Diseases. 2009, WB Saunders, Philadelphia, PA, 2462-2487.
5. Simoes EA, Carbonell-Estrany X: Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003, 22 (2 Suppl): S13-18. discussion S18-20
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献